The Oncosearch | Oncotarget

Retraction: miR-135a promotes gastric cancer progression and resistance to oxaliplatin Retraction

Lin-Hai Yan, Zhi-Ning Chen, Li-Li, Jia Chen, Wen-E Wei, Xian-Wei Mo, Yu-Zhou Qin, Yuan Lin, Jian-Si Chen

Published Apr 1, 2026 · Vol. 17, No. 1 · pp. 119-119

Exceptional responders to immunotherapy in pancreatic cancer: A multi-institutional case series of a rare occurrence Research Paper

Kavin Sugumar, Andrew Alabd, Andre Alabd, Jonathan J. Hue, Josh Lyons, Sherri Fields, Zev Wainberg, Lei Zheng, Brianna Coogle, Anup Kasi, Nicholas Grewal, Hedy L. Kindler, Jason Starr, Ashwin R. Sama, Jordan M. Winter

Published Jun 3, 2025 · Vol. 16, No. 1 · pp. 427-442

Keywords: pancreatic adenocarcinoma, immunotherapy, exceptional responders, microsatellite instability, survival

Could Panitumumab with very low dose Capecitabine be an option as a maintenance regimen Research Paper

Doaa A. Gamal, Aiat Morsy, Mervat Omar

Published Jan 29, 2025 · Vol. 16, No. 1 · pp. 67-78

Keywords: Panitumumab, maintenance, colorectal cancer, Capecitabine

Real time ex vivo chemosensitivity assay for pancreatic adenocarcinoma Research Paper

Dae Won Kim, Francisca Beato, Youngchul Kim, Alexandra F. Tassielli, Ruifan Dai, Jason W. Denbo, Pamela J. Hodul, Mokenge P. Malafa, Jason B. Fleming

Published Sep 7, 2023 · Vol. 14, No. 1 · pp. 811-818

Keywords: pancreatic cancer, sensitivity assay, chemotherapy

In vitro chemotherapy-associated muscle toxicity is attenuated with nutritional support, while treatment efficacy is retained Research Paper

Liza A. Wijler, Francina J. Dijk, Hanil Quirindongo, Danielle A.E. Raats, Bram Dorresteijn, Matthew J.W. Furber, Anne M. May, Onno Kranenburg, Miriam van Dijk

Published Sep 27, 2022 · Vol. 13, No. 1 · pp. 1094-1108

Keywords: C2C12 myotubes, chemotherapy, chemotherapy-associated toxicity, colorectal cancer, nutrients, tumor (organoid) cells

Pan-drug and drug-specific mechanisms of 5-FU, irinotecan (CPT-11), oxaliplatin, and cisplatin identified by comparison of transcriptomic and cytokine responses of colorectal cancer cells Research Paper

Lindsey Carlsen, Christoph Schorl, Kelsey Huntington, Liz Hernandez-Borrero, Aakash Jhaveri, Shengliang Zhang, Lanlan Zhou, Wafik S. El-Deiry

Published Sep 8, 2021 · Vol. 12, No. 20 · pp. 2006-2021

Keywords: chemotherapy mechanism, colon cancer, 5-fluorouracil, irinotecan, oxaliplatin

Glucocorticoid receptor antagonism promotes apoptosis in solid tumor cells Research Paper

Andrew E. Greenstein, Hazel J. Hunt

Published Jun 9, 2021 · Vol. 12, No. 13 · pp. 1243-1255

Keywords: glucocorticoid, tumors, apoptosis, chemotherapy, drug resistance

The acylfulvene alkylating agent, LP-184, retains nanomolar potency in non-small cell lung cancer carrying otherwise therapy-refractory mutations Research Paper

Aditya Kulkarni, Joseph Ryan McDermott, Umesh Kathad, Rama Modali, Jean-Philippe Richard, Panna Sharma, Kishor Bhatia

Published Apr 5, 2021 · Vol. 12, No. 8 · pp. 791-806

Keywords: non-small cell lung cancer, acylfulvene, alkylating agent, PTGR1, LP-184

MicroRNA-214 enriched exosomes from human cerebral endothelial cells (hCEC) sensitize hepatocellular carcinoma to anti-cancer drugs Research Paper

Louie Semaan, Qingning Zeng, Yong Lu, Yi Zhang, Mehdi Mohamad Zreik, Mohamad Baqer Chamseddine, Michael Chopp, Zheng Gang Zhang, Dilip Moonka

Published Jan 25, 2021 · Vol. 12, No. 3 · pp. 185-198

Keywords: hepatocellular carcinoma (HCC), human cerebral endothelial cells-derived exosomes, microRNA-214, therapeutic efficacy, anti-cancer drug

Damage-associated molecular pattern (DAMP) activation in melanoma: investigation of the immunogenic activity of 15-deoxy, Δ^12,14 prostamide J₂ Research Paper

Ahmed Elhassanny, Rene Escobedo, Daniel Ladin, Colin Burns, Rukiyah Van Dross

Published Dec 22, 2020 · Vol. 11, No. 52 · pp. 4788-4802

Keywords: calreticulin, endoplasmic reticulum stress, dendritic cells, endocannabinoid metabolite

Correction: Improved anti-tumor efficacy via combination of oxaliplatin and fibrin glue in colorectal cancer Correction

Yuzhu Hu, Ting Yu, Xiaoxiao Liu, Yihong He, Lihong Deng, Jiajuan Guo, Yuanqi Hua, Ting Luo, Xiang Gao

Published May 7, 2020 · Vol. 11, No. 37 · pp. 3484-3485

Prognostic and predictive factors in pancreatic cancer Review

Emanuela Dell’Aquila, Claudia Angela Maria Fulgenzi, Alessandro Minelli, Fabrizio Citarella, Marco Stellato, Francesco Pantano, Marco Russano, Maria Concetta Cursano, Andrea Napolitano, Tea Zeppola, Bruno Vincenzi, Giuseppe Tonini, Daniele Santini

Published Mar 10, 2020 · Vol. 11, No. 10 · pp. 924-941

Keywords: metastatic pancreatic cancer, predictive and prognostic factors, CA19-9, gemcitabine-abraxane, FOLFIRINOX

Oxaliplatin-induced neuropathy: the preventive effect of a new super-oxide dismutase modulator Research Paper

Marie-Anne Guillaumot, Olivier Cerles, Hélène C. Bertrand, Evelyne Benoit, Carole Nicco, Sandrine Chouzenoux, Alain Schmitt, Frédéric Batteux, Clotilde Policar, Romain Coriat

Published Nov 5, 2019 · Vol. 10, No. 60 · pp. 6418-6431

Keywords: oxidative stress, super oxide dismutase, oxaliplatine, cancer cell, chemotherapy toxicities

Excision repair cross-complementing group-1 (ERCC1) induction kinetics and polymorphism are markers of inferior outcome in patients with colorectal cancer treated with oxaliplatin Research Paper

Devika Rao, Atrayee Basu Mallick, Titto Augustine, Cecilia Daroqui, Jeeshan Jiffry, Amartej Merla, Imran Chaudhary, Raviraja Seetharam, Arjun Sood, Srikanth Gajavelli, Santiago Aparo, Lakshmi Rajdev, Andreas Kaubisch, Jennifer Chuy, Abdissa Negassa, John M. Mariadason, Radhashree Maitra, Sanjay Goel

Published Sep 17, 2019 · Vol. 10, No. 53 · pp. 5510-5522

Keywords: oxaliplatin, colorectal cancer, ERCC1, FOLFOX, resistance

Multidisciplinary palliation for unresectable recurrent rectal cancer: hypoxic pelvic perfusion with mitomycin C and oxaliplatin in patients progressing after systemic chemotherapy and radiotherapy, a retrospective cohort study Research Paper

Stefano Guadagni, Giammaria Fiorentini, Andrea Mambrini, Francesco Masedu, Marco Valenti, Andrew Reay Mackay, Donatella Sarti, Enrico Ricevuto, Marco Clementi, Marco Catarci, Gianni Lazzarin, Gemma Bruera

Published Jun 11, 2019 · Vol. 10, No. 39 · pp. 3840-3851

Keywords: hypoxic pelvic perfusion with mitomycin C and oxaliplatin, unresectable recurrent rectal cancer, retrospective cohort study

Investigating the role of LSD2 as an epigenetic regulator in Ewing sarcoma Review

Stefano Guadagni, Giammaria Fiorentini, Andrea Mambrini, Francesco Masedu, Marco Valenti, Andrew Reay Mackay, Donatella Sarti, Enrico Ricevuto, Marco Clementi, Marco Catarci, Gianni Lazzarin, Gemma Bruera

Published May 14, 2019

Keywords: hypoxic pelvic perfusion with mitomycin C and oxaliplatin, unresectable recurrent rectal cancer, retrospective cohort study

Pedf derived peptides affect colorectal cancer cell lines resistance and tumour re-growth capacity Research Paper

Paloma Honrubia-GÃ³mez, MarÃa-Pilar LÃ³pez-Garrido, Carmen Gil-Gas, JosÃ© SÃ¡nchez-SÃ¡nchez, Carmen Alvarez-Simon, Jorge Cuenca-Escalona, Ana Ferrer Perez, Enrique Arias, Raul Moreno, Francisco SÃ¡nchez-SÃ¡nchez, Carmen Ramirez-Castillejo

Published Apr 26, 2019 · Vol. 10, No. 31 · pp. 2973-2986

Influence of initial dose intensity on efficacy of FOLFIRINOX in patients with advanced pancreatic cancer Research Paper

Satoshi Kobayashi, Makoto Ueno, Katsuhiro Omae, Hidekazu Kuramochi, Masato Terao, Nobumasa Mizuno, Masato Ozaka, Hideki Ueno, Kazuhiro Uesugi, Noritoshi Kobayashi, Marina Kobayashi, Akiko Todaka, Akira Fukutomi

Published Mar 5, 2019 · Vol. 10, No. 19 · pp. 1775-1784

Body surface area-based versus concentration-based intraperitoneal perioperative chemotherapy in a rat model of colorectal peritoneal surface malignancy: pharmacologic guidance towards standardization Research Paper

Lieselotte Lemoine, Elsy Thijssen, Robert Carleer, Jirka Cops, Veerle Lemmens, Peter Van Eyken, Paul Sugarbaker, Kurt Van der Speeten

Published Feb 15, 2019 · Vol. 10, No. 14 · pp. 1407-1424

Bevacizumab as a chemoprotectant: reducing oxaliplatin induced hepatic sinusoidal injury Editorial

Jonathan D. Mizrahi, Michael J. Overman

Published Sep 28, 2018 · Vol. 9, No. 79 · pp. 34857-34858

Publication Alerts

European Cancer and Oncology Congress

Post-Publication Promotion

Search Oncotarget

Retraction: miR-135a promotes gastric cancer progression and resistance to oxaliplatin Retraction

Exceptional responders to immunotherapy in pancreatic cancer: A multi-institutional case series of a rare occurrence Research Paper

Could Panitumumab with very low dose Capecitabine be an option as a maintenance regimen Research Paper

Real time ex vivo chemosensitivity assay for pancreatic adenocarcinoma Research Paper

In vitro chemotherapy-associated muscle toxicity is attenuated with nutritional support, while treatment efficacy is retained Research Paper

Pan-drug and drug-specific mechanisms of 5-FU, irinotecan (CPT-11), oxaliplatin, and cisplatin identified by comparison of transcriptomic and cytokine responses of colorectal cancer cells Research Paper

Glucocorticoid receptor antagonism promotes apoptosis in solid tumor cells Research Paper

The acylfulvene alkylating agent, LP-184, retains nanomolar potency in non-small cell lung cancer carrying otherwise therapy-refractory mutations Research Paper

MicroRNA-214 enriched exosomes from human cerebral endothelial cells (hCEC) sensitize hepatocellular carcinoma to anti-cancer drugs Research Paper

Damage-associated molecular pattern (DAMP) activation in melanoma: investigation of the immunogenic activity of 15-deoxy, Δ^12,14 prostamide J₂ Research Paper

Correction: Improved anti-tumor efficacy via combination of oxaliplatin and fibrin glue in colorectal cancer Correction

Prognostic and predictive factors in pancreatic cancer Review

Oxaliplatin-induced neuropathy: the preventive effect of a new super-oxide dismutase modulator Research Paper

Excision repair cross-complementing group-1 (ERCC1) induction kinetics and polymorphism are markers of inferior outcome in patients with colorectal cancer treated with oxaliplatin Research Paper

Multidisciplinary palliation for unresectable recurrent rectal cancer: hypoxic pelvic perfusion with mitomycin C and oxaliplatin in patients progressing after systemic chemotherapy and radiotherapy, a retrospective cohort study Research Paper

Investigating the role of LSD2 as an epigenetic regulator in Ewing sarcoma Review

Pedf derived peptides affect colorectal cancer cell lines resistance and tumour re-growth capacity Research Paper

Influence of initial dose intensity on efficacy of FOLFIRINOX in patients with advanced pancreatic cancer Research Paper

Body surface area-based versus concentration-based intraperitoneal perioperative chemotherapy in a rat model of colorectal peritoneal surface malignancy: pharmacologic guidance towards standardization Research Paper

Bevacizumab as a chemoprotectant: reducing oxaliplatin induced hepatic sinusoidal injury Editorial

Publication Alerts

European Cancer and Oncology Congress

Oncoscience

Post-Publication Promotion

Search Oncotarget

Retraction: miR-135a promotes gastric cancer progression and resistance to oxaliplatin Retraction

Exceptional responders to immunotherapy in pancreatic cancer: A multi-institutional case series of a rare occurrence Research Paper

Could Panitumumab with very low dose Capecitabine be an option as a maintenance regimen Research Paper

Real time ex vivo chemosensitivity assay for pancreatic adenocarcinoma Research Paper

In vitro chemotherapy-associated muscle toxicity is attenuated with nutritional support, while treatment efficacy is retained Research Paper

Pan-drug and drug-specific mechanisms of 5-FU, irinotecan (CPT-11), oxaliplatin, and cisplatin identified by comparison of transcriptomic and cytokine responses of colorectal cancer cells Research Paper

Glucocorticoid receptor antagonism promotes apoptosis in solid tumor cells Research Paper

The acylfulvene alkylating agent, LP-184, retains nanomolar potency in non-small cell lung cancer carrying otherwise therapy-refractory mutations Research Paper

MicroRNA-214 enriched exosomes from human cerebral endothelial cells (hCEC) sensitize hepatocellular carcinoma to anti-cancer drugs Research Paper

Damage-associated molecular pattern (DAMP) activation in melanoma: investigation of the immunogenic activity of 15-deoxy, Δ12,14 prostamide J2 Research Paper

Correction: Improved anti-tumor efficacy via combination of oxaliplatin and fibrin glue in colorectal cancer Correction

Prognostic and predictive factors in pancreatic cancer Review

Oxaliplatin-induced neuropathy: the preventive effect of a new super-oxide dismutase modulator Research Paper

Excision repair cross-complementing group-1 (ERCC1) induction kinetics and polymorphism are markers of inferior outcome in patients with colorectal cancer treated with oxaliplatin Research Paper

Multidisciplinary palliation for unresectable recurrent rectal cancer: hypoxic pelvic perfusion with mitomycin C and oxaliplatin in patients progressing after systemic chemotherapy and radiotherapy, a retrospective cohort study Research Paper

Investigating the role of LSD2 as an epigenetic regulator in Ewing sarcoma Review

Pedf derived peptides affect colorectal cancer cell lines resistance and tumour re-growth capacity Research Paper

Influence of initial dose intensity on efficacy of FOLFIRINOX in patients with advanced pancreatic cancer Research Paper

Body surface area-based versus concentration-based intraperitoneal perioperative chemotherapy in a rat model of colorectal peritoneal surface malignancy: pharmacologic guidance towards standardization Research Paper

Bevacizumab as a chemoprotectant: reducing oxaliplatin induced hepatic sinusoidal injury Editorial

Damage-associated molecular pattern (DAMP) activation in melanoma: investigation of the immunogenic activity of 15-deoxy, Δ^12,14 prostamide J₂ Research Paper